QA: Sagent Pharmaceuticals Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001369786_2014_Sagent_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001369786, Sagent Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 235,791,000
1 IntangibleAssetsNetIncludingGoodwill 14,364,000
2 PropertyPlantAndEquipmentNet 57,684,000
3 remainder_Assets 2,369,000
4 LiabilitiesCurrent 63,524,000
5 LiabilitiesNoncurrent 2,329,000
6 remainder_Liabilities 8,329,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,198,000
9 ResearchAndDevelopmentExpense 20,275,000
10 remainder_Expenses 166,658,000
11 remainder_Revenues 244,789,000
12 remainder_NetIncome 7,936,000
13 remainder_ComprehensiveNetIncome -2,013,000
  yvar yval
0 Assets 310,208,000
1 Liabilities 74,182,000
2 Expenses 223,131,000
3 Revenues 244,789,000
4 StockholdersEquity 236,026,000
5 NetIncome 29,594,000
6 ComprehensiveNetIncome 28,587,500
7 BaseVar 431,129,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.83
9 EconomicCapitalRatio 3.57

Edgar->Model Mapping

Feature Distribution

Change over Time